Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Construction of a 5-methylcytosine-Related Molecular Signature to Inform the Prognosis and Immunotherapy of Lung Squamous Cell Carcinoma

2 Sept 2022

Abstract excerpt

BACKGROUND: Methylation of cytosine residues resulting in 5-methylcytosine (5-mC) is an important epigenetic modification associated with tumorigenesis. The present study explored the relationship between methylation, prognosis, and immunotherapy of patients suffering from lung squamous cell carcinoma (LUSC). METHODS: RNA sequencing data and corresponding clinical information were downloaded, and preprocessed,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to Epigenetics and DNA Methylation
Share to Ferroptosis and cancer prognosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36197838
DOI: 10.1080/14737159.2022.2131396

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Construction of a 5-methylcytosine-Related Molecular Signature to Inform the Prognosis and Immunotherapy of Lung Squamous Cell CarcinomaPMID 36197838Read ↗

5-methylcytosine RNA methylation regulators affect prognosis and tumor microenvironment in lung adenocarcinomaSemantic proximity Read ↗

Characterization of m6A RNA Methylation Regulators Predicts Survival and Immunotherapy in Lung Adenocarcinoma.Semantic proximity Read ↗

Integration of multi-omics profiling reveals an epigenetic-based molecular classification of lung adenocarcinoma: implications for drug sensitivity and immunotherapy response predictionSemantic proximity Read ↗

A prognostic 11-DNA methylation signature for lung squamous cell carcinomaSemantic proximity Read ↗

Molecular Subtypes Based on DNA Methylation Predict Prognosis in Lung Squamous Cell CarcinomaSemantic proximity Read ↗

Novel Molecular Subtypes Associated With 5mC Methylation and Their Role in Hepatocellular Carcinoma ImmunotherapySemantic proximity Read ↗

Comprehensive Analysis of the Function, Immune Profiles, and Clinical Implication of m1A Regulators in Lung AdenocarcinomaSemantic proximity Read ↗

Signatures of Multi-Omics Reveal Distinct Tumor Immune Microenvironment Contributing to Immunotherapy in Lung AdenocarcinomaSemantic proximity Read ↗

Characteristic of Classification and Prognostic Scoring Based on M6a RNA Methylation Modification in Lung Adenocarcinoma and Tumor Microenvironment AssociationSemantic proximity Read ↗

Comprehensive Analysis of Epigenetic Alternations of MicroRNA and DNA Methylation Contribute to Gene Expression and Prognosis in Lung Squamous Cell CarcinomaSemantic proximity Read ↗

Molecular subtypes based on DNA methylation predict prognosis in lung squamous cell carcinomaSemantic proximity Read ↗

Development and validation of a 5mC-based prognostic model for lung adenocarcinoma survival.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.